Polymeropoulos Mihael Hristos
CIK 0001355537 Name as filed on the most recent filing
Filed as Polymeropoulos Mihael Hristos (51)
147 transaction lines · from 51 filings · filed 2006-11-08 to 2026-03-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
147 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 156,235 disposed | 8.17 | 1,276,971.15 | Form 4, filing 0001355537-26-000002 | |
| 2025-08-07 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 10,000 acquired | 4.15 | 41,500.00 | Form 4, filing 0000950170-25-105819 | |
| 2025-05-21 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 9,519 acquired | 4.40 | 41,883.60 | Form 4, filing 0000950170-25-076012 | |
| 2025-05-21 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 481 acquired | 4.39 | 2,111.59 | Form 4, filing 0000950170-25-076012 | |
| 2025-05-16 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 20,000 acquired | 4.22 | 84,472.00 | Form 4, filing 0000950170-25-074565 | |
| 2025-03-06 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 5,000 acquired | 5.02 | 25,100.00 | Form 4, filing 0000950170-25-034966 | |
| 2025-03-06 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 5,000 acquired | 5.01 | 25,050.00 | Form 4, filing 0000950170-25-034966 | |
| 2025-03-05 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 5,000 acquired | 5.03 | 25,150.00 | Form 4, filing 0000950170-25-033845 | |
| 2025-03-05 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 5,000 acquired | 5.01 | 25,050.00 | Form 4, filing 0000950170-25-033845 | |
| 2025-03-03 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 10,000 acquired | 4.70 | 47,050.00 | Form 4, filing 0000950170-25-032276 | |
| 2025-02-28 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 10,000 acquired | 4.76 | 47,600.00 | Form 4, filing 0000950170-25-030176 | |
| 2025-02-27 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 10,000 acquired | 4.76 | 47,600.00 | Form 4, filing 0000950170-25-029059 | |
| 2025-02-26 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 5,000 acquired | 4.78 | 23,900.00 | Form 4, filing 0000950170-25-027860 | |
| 2025-02-26 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 5,000 acquired | 4.75 | 23,750.00 | Form 4, filing 0000950170-25-027860 | |
| 2025-02-25 |
Vanda Pharmaceuticals Inc. VNDA |
P, Open-market purchase | 10,000 acquired | 4.46 | 44,640.00 | Form 4, filing 0000950170-25-027056 | |
| 2024-03-05 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 24,288 disposed | 4.13 | 100,273.01 | Form 4, filing 0000950170-24-027256 | |
| 2024-03-04 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 30,884 disposed | 4.24 | 131,065.52 | Form 4, filing 0000950170-24-027256 | |
| 2023-03-03 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 22,538 disposed | 6.25 | 140,876.02 | Form 4, filing 0001209191-23-016462 | |
| 2023-03-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 22,426 disposed | 6.23 | 139,718.47 | Form 4, filing 0001209191-23-016462 | |
| 2022-12-06 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 48,250 disposed | 10.61 | 512,082.08 | Form 4, filing 0001209191-22-060227 | |
| 2022-12-05 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 47,650 disposed | 10.62 | 506,200.24 | Form 4, filing 0001209191-22-060227 | |
| 2022-03-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 29,588 disposed | 11.15 | 329,944.66 | Form 4, filing 0001209191-22-015157 | |
| 2022-03-01 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 7,508 disposed | 11.19 | 84,014.52 | Form 4, filing 0001209191-22-015157 | |
| 2021-12-01 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 46,200 disposed | 16.00 | 739,347.84 | Form 4, filing 0001209191-21-067592 | |
| 2021-11-30 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 50,000 disposed | 16.49 | 824,275.00 | Form 4, filing 0001209191-21-067592 | |
| 2021-03-08 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 175,000 disposed | 18.00 | 3,150,052.50 | Form 4, filing 0001209191-21-019118 | |
| 2021-03-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 15,206 disposed | 18.34 | 278,902.37 | Form 4, filing 0001209191-21-017276 | |
| 2021-03-01 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 7,479 disposed | 18.45 | 138,002.51 | Form 4, filing 0001209191-21-017276 | |
| 2020-12-15 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 39,150 disposed | 13.00 | 508,844.30 | Form 4, filing 0001209191-20-063474 | |
| 2020-12-14 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 51,049 disposed | 13.19 | 673,305.68 | Form 4, filing 0001209191-20-063474 | |
| 2020-12-11 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 35,053 disposed | 12.88 | 451,359.95 | Form 4, filing 0001209191-20-063474 | |
| 2020-03-03 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 5,152 disposed | 10.98 | 56,544.23 | Form 4, filing 0001209191-20-016204 | |
| 2020-03-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 10,428 disposed | 10.57 | 110,211.45 | Form 4, filing 0001209191-20-016204 | |
| 2020-01-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 9,467 disposed | 16.00 | 151,492.83 | Form 4, filing 0001209191-20-002031 | |
| 2019-12-12 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 70,036 disposed | 16.98 | 1,189,351.35 | Form 4, filing 0001209191-19-060380 | |
| 2019-12-11 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 72,373 disposed | 16.92 | 1,224,377.46 | Form 4, filing 0001209191-19-060380 | |
| 2019-05-21 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 72,872 disposed | 15.34 | 1,117,951.21 | Form 4, filing 0001209191-19-031781 | |
| 2019-05-20 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 67,418 disposed | 15.12 | 1,019,083.75 | Form 4, filing 0001209191-19-031781 | |
| 2019-05-17 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 77,225 disposed | 15.56 | 1,201,690.50 | Form 4, filing 0001209191-19-031781 | |
| 2019-03-04 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 38,166 disposed | 19.41 | 740,802.06 | Form 4, filing 0001209191-19-015746 | |
| 2019-03-01 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 6,500 disposed | 20.22 | 131,423.50 | Form 4, filing 0001209191-19-015746 | |
| 2019-01-03 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 4,447 disposed | 26.04 | 115,804.33 | Form 4, filing 0001209191-19-001979 | |
| 2019-01-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 7,733 disposed | 26.32 | 203,548.03 | Form 4, filing 0001209191-19-001979 | |
| 2019-01-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 3,056 disposed | 26.93 | 82,310.30 | Form 4, filing 0001209191-19-001979 | |
| 2018-03-01 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 60,966 disposed | 18.72 | 1,141,003.08 | Form 4, filing 0001209191-18-015887 | |
| 2018-01-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 170,225 disposed | 15.30 | 2,603,727.56 | Form 4, filing 0001209191-18-002064 | |
| 2018-01-02 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 21,535 disposed | 15.30 | 329,399.36 | Form 4, filing 0001209191-18-002064 | |
| 2017-01-03 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 23,330 disposed | 15.48 | 361,241.72 | Form 4, filing 0001209191-17-002190 | |
| 2016-01-04 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 21,353 disposed | 8.96 | 191,322.88 | Form 4, filing 0001209191-16-090127 | |
| 2015-09-10 |
Vanda Pharmaceuticals Inc. VNDA |
S, Open-market sale | 102,162 disposed | 12.73 | 1,300,501.83 | Form 4, filing 0001209191-15-070343 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 28
- Open-market sale 119
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Polymeropoulos Mihael Hristos, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001355537
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6